[go: up one dir, main page]

YU48602B - Postupak za dobijanje stabilne formulacije soli enalaprila - Google Patents

Postupak za dobijanje stabilne formulacije soli enalaprila

Info

Publication number
YU48602B
YU48602B YU184291A YU184291A YU48602B YU 48602 B YU48602 B YU 48602B YU 184291 A YU184291 A YU 184291A YU 184291 A YU184291 A YU 184291A YU 48602 B YU48602 B YU 48602B
Authority
YU
Yugoslavia
Prior art keywords
sodium
stable formulation
enalaprile
salts
procedure
Prior art date
Application number
YU184291A
Other languages
English (en)
Other versions
YU184291A (sh
Inventor
Marjo dr. Merslavič
Jožica dipl. ing. Ražen
Aleš mag. Rotar
Original Assignee
Krka Tovarna Zdravil P.O.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=25555813&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=YU48602(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Krka Tovarna Zdravil P.O. filed Critical Krka Tovarna Zdravil P.O.
Priority to YU184291A priority Critical patent/YU48602B/sh
Priority to SI9111842A priority patent/SI9111842A/sl
Priority to EP92119896A priority patent/EP0545194B1/en
Priority to ES92119896T priority patent/ES2101004T3/es
Priority to DE69218557T priority patent/DE69218557T2/de
Priority to AT92119896T priority patent/ATE150650T1/de
Priority to DK92119896.6T priority patent/DK0545194T3/da
Priority to US07/980,956 priority patent/US5350582A/en
Priority to CA002083683A priority patent/CA2083683C/en
Priority to HRP-1842/91A priority patent/HRP921482B1/xx
Publication of YU184291A publication Critical patent/YU184291A/sh
Priority to GR970401299T priority patent/GR3023655T3/el
Publication of YU48602B publication Critical patent/YU48602B/sh

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55Protease inhibitors
    • A61K38/556Angiotensin converting enzyme inhibitors

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Vascular Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)

Abstract

Postupak za dobijanje stabilne formulacije soli enalaprila formule I, naznačen time, što jedinjenja formule II suspendujemo u demineralizovanoj vodi i dodamo stehiometrisku količinu odgovarajućeg natrijumovog jedinjenja, kao što su natrijum karbonat, natrijum hidrogenkarbonat ili natrijum hidroksid, pa toj IN SITU pripremljenoj natrijumovoj soli enalaprila formule I dodamo formulisane dodatke, homogenizujemo i formulišemo.
YU184291A 1991-11-25 1991-11-25 Postupak za dobijanje stabilne formulacije soli enalaprila YU48602B (sh)

Priority Applications (11)

Application Number Priority Date Filing Date Title
YU184291A YU48602B (sh) 1991-11-25 1991-11-25 Postupak za dobijanje stabilne formulacije soli enalaprila
SI9111842A SI9111842A (sl) 1991-11-25 1991-11-25 Stabilna formulacija soli enalaprila, postopek za njeno pripravo in njena uporaba
DK92119896.6T DK0545194T3 (da) 1991-11-25 1992-11-23 Stabil formulering af enaprilsalt, fremgangsmåde til fremstilling deraf og anvendelse deraf.
DE69218557T DE69218557T2 (de) 1991-11-25 1992-11-23 Stabile Zusammensetzung die ein Enalapril-Salz enthält, Verfahren zu ihrer Herstellung und ihre Verwendung
ES92119896T ES2101004T3 (es) 1991-11-25 1992-11-23 Formulacion estable de sales del enalapril, procedimiento para su preparacion y su uso.
EP92119896A EP0545194B1 (en) 1991-11-25 1992-11-23 Stable formulation of enalapril salt, a process for the preparation thereof and the use thereof
AT92119896T ATE150650T1 (de) 1991-11-25 1992-11-23 Stabile zusammensetzung die ein enalapril-salz enthält, verfahren zu ihrer herstellung und ihre verwendung
US07/980,956 US5350582A (en) 1991-11-25 1992-11-24 Stable formulation of enalapril salt, a process for the preparation thereof and the use thereof
CA002083683A CA2083683C (en) 1991-11-25 1992-11-24 Stable formulation of analapril salt, a process for the preparation thereof and the use thereof
HRP-1842/91A HRP921482B1 (en) 1991-11-25 1992-12-30 Stable formulation of enalapril salt, a process for the preparation thereof and the use thereof
GR970401299T GR3023655T3 (en) 1991-11-25 1997-06-04 Stable formulation of enalapril salt, a process for the preparation thereof and the use thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
YU184291A YU48602B (sh) 1991-11-25 1991-11-25 Postupak za dobijanje stabilne formulacije soli enalaprila

Publications (2)

Publication Number Publication Date
YU184291A YU184291A (sh) 1994-04-05
YU48602B true YU48602B (sh) 1998-12-23

Family

ID=25555813

Family Applications (1)

Application Number Title Priority Date Filing Date
YU184291A YU48602B (sh) 1991-11-25 1991-11-25 Postupak za dobijanje stabilne formulacije soli enalaprila

Country Status (11)

Country Link
US (1) US5350582A (sh)
EP (1) EP0545194B1 (sh)
AT (1) ATE150650T1 (sh)
CA (1) CA2083683C (sh)
DE (1) DE69218557T2 (sh)
DK (1) DK0545194T3 (sh)
ES (1) ES2101004T3 (sh)
GR (1) GR3023655T3 (sh)
HR (1) HRP921482B1 (sh)
SI (1) SI9111842A (sh)
YU (1) YU48602B (sh)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5562921A (en) * 1994-07-15 1996-10-08 Sherman; Bernard C. Stable solid pharmaceutical compositions containing enalapril maleate
US5573780A (en) * 1995-08-04 1996-11-12 Apotex Usa Inc. Stable solid formulation of enalapril salt and process for preparation thereof
GB9521781D0 (en) * 1995-10-24 1996-01-03 Merck Sharp & Dohme Therapeutic agents
RU2140261C1 (ru) * 1997-04-03 1999-10-27 Открытое акционерное общество "АЙ СИ ЭН Лексредства" Твердая лекарственная форма на основе малеата эналаприла
ES2125198B1 (es) * 1997-05-13 1999-11-16 Vita Invest Sa Asociacion a dosis fija de un inhibidor de la enzima convertidora de angiotensina y de un antagonista de los canales de calcio, procedimiento para su preparacion y su utilizacion para el tratamiento de enfermees cardiovasculares.
KR20010023450A (ko) * 1998-07-21 2001-03-26 후루타 다케시 엔-(1(에스)-에톡시카르보닐-3-페닐프로필)-엘-아라닐-엘-프롤린의 말레인산염의 정출방법
NZ333206A (en) 1998-12-08 2000-07-28 Bernard Charles Sherman Solid pharmaceutical compositions comprising a stable magnesium salt of quinapril that acts as a ACE (Angiotensin Converting Enzyme) inhibitor
US6637359B1 (en) * 1998-12-15 2003-10-28 Maritrans Inc. System and method for internally fitting a new inner hull to an existing outer hull to form a rebuilt double hull vessel
US20040157911A1 (en) * 1999-08-31 2004-08-12 Spiridon Spireas Storage-stable and bio-stable formulations of ace inhibitors, and methods for preparation thereof
US6555551B1 (en) 1999-08-31 2003-04-29 Mutual Pharmaceutical Co., Inc. Stable formulations of ACE inhibitors, and methods for preparation thereof
US6764694B1 (en) * 1999-08-31 2004-07-20 Mutual Pharmaceutical Co., Inc. Stable formulations of ACE inhibitors, and methods for preparation thereof
US20030225124A1 (en) * 1999-08-31 2003-12-04 Spiridon Spireas Stable formulations of ACE inhibitors, and methods for preparation thereof
HU226950B1 (en) * 1999-11-03 2010-03-29 Richter Gedeon Nyrt The magnesium salt of enalapril and antihypertensive pharmaceutical composition containing it
US20030215526A1 (en) * 2002-03-08 2003-11-20 Scott Stofik Stable formulations of angiotensin converting enzyme (ACE) inhibitors
ES2603856T3 (es) * 2004-03-29 2017-03-01 Les Laboratoires Servier Procedimiento para preparar una composición farmacéutica sólida
SI21800A (sl) * 2004-05-14 2005-12-31 Krka, Tovarna Zdravil, D.D., Novo Mesto Nov postopek sinteze perindoprila
PL1948224T3 (pl) 2005-11-17 2014-10-31 Silverstone Pharma Est Trwały preparat amorficznych soli peryndoprylu, sposób ich wytwarzania, zwłaszcza wytwarzania w skali przemysłowej oraz ich zastosowanie w terapii nadciśnienia
SI23149A (sl) 2009-09-21 2011-03-31 Silverstone Pharma Nove benzatinske soli ACE inhibitorjev, postopek za njihovo pripravo in njihova uporaba za zdravljenje kardiovaskularnih bolezni
SI2585051T2 (sl) 2010-06-23 2020-07-31 Krka, D.D., Novo Mesto Farmacevtske oralne odmerne oblike,ki obsegajo lerkanidipin in enalapril in njune farmacevtsko sprejemljive soli
EA023996B1 (ru) 2010-12-24 2016-08-31 КРКА, д.д., НОВО МЕСТО Гомогенные фармацевтические пероральные лекарственные формы, содержащие лерканидипин и эналаприл или их фармацевтически приемлемые соли совместно с органической кислотой
WO2015031676A2 (en) 2013-08-28 2015-03-05 Psychemedics Corporation Integrity testing of hair samples
WO2016015798A1 (en) 2014-07-31 2016-02-04 Pharmathen S.A. Orodispersible film composition comprising enalapril for the treatment of hypertension in a pediatric population

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4830853A (en) * 1986-10-20 1989-05-16 Warner-Lambert Company Drug compositions stabilized against oxidation
US4743450A (en) * 1987-02-24 1988-05-10 Warner-Lambert Company Stabilized compositions
EP0391462A1 (en) * 1989-04-05 1990-10-10 Janssen Pharmaceutica N.V. Synergistic compositions containing ketanserin

Also Published As

Publication number Publication date
YU184291A (sh) 1994-04-05
EP0545194A1 (en) 1993-06-09
GR3023655T3 (en) 1997-09-30
HRP921482B1 (en) 2000-04-30
CA2083683C (en) 2000-09-05
SI9111842A (sl) 1998-04-30
DK0545194T3 (da) 1997-07-28
HRP921482A2 (en) 1996-12-31
CA2083683A1 (en) 1993-05-26
US5350582A (en) 1994-09-27
ATE150650T1 (de) 1997-04-15
DE69218557D1 (de) 1997-04-30
ES2101004T3 (es) 1997-07-01
DE69218557T2 (de) 1997-11-13
EP0545194B1 (en) 1997-03-26

Similar Documents

Publication Publication Date Title
YU48602B (sh) Postupak za dobijanje stabilne formulacije soli enalaprila
IL70540A (en) Plant bactericidal and fungicidal compositions containing 1-cycloproply-quinolonecarboxylic acid and method for using them
ES8503355A1 (es) Procedimiento de preparacion de nuevas sales de derivados organofosforados
ES8601800A1 (es) Un procedimiento para sintetizar una zeolita cristalina, que contiene potasio
CA2047783A1 (en) Stable solution of sodium hypochlorite
IL75389A (en) Synergistic plant growth regulative compositions containing a phenylimidazolecarboxylic acid derivative
HU901193D0 (en) Process for protection against phytopathogenic bacteria using phosphonic acid derivatives
FI843354A0 (fi) Foerfarande foer framstaellning av nya 4-fenyl-4-oxo-2-ensmoersyraderivat.
ZA871757B (en) 1-phenylimidazolecarboxylic acid amides,their preparation and their use as growth regulators
DE3164005D1 (en) Use of alpha-azolylglycoles as plant growth regulators
MX9705836A (es) Sales de zinc del acido citraconamico y compuestos de hule que contienen estas sales.
EG19154A (en) Antiviral highly water soluble, stable, cujstaline salts of 2,3 dideoxyinosine monohydrate,2,3 dideoxy 2,3 didehydrothumidine monohydrate and 2,3 - dideoxy-2- fluoroinosine hemilydrate
GR82365B (sh)
ZA841418B (en) N-arylpiperazine derivatives
DE3262339D1 (en) Herbicidal agents
IL75742A0 (en) Phenylethylaminopropiophenone derivatives,their preparation and pharmaceutical compositions containing them
DE69608260D1 (en) Wässrige spectinomycinborat-auflösung
GR3007320T3 (sh)
HUT38090A (en) Process for production of derivatives of 2,2,5,2-tetraalkyl-cyclohexan-4-on-1-ol
ES8500266A1 (es) "procedimiento para la preparacion de nuevos acidos benzoilparabanicos"
SE8400451D0 (sv) Bronchodilatory azepino /1,2-a/pyrimidine derivatives and acid addition salts thereof and pharmaceutical compositions containig same
GR862329B (en) Method for the preparation of bromo-fluoro-acetics